Previous studies have demonstrated that SERPINA3 expression is significantly enhanced in glioma and associated with poor prognosis for glioma patients, moreover, its expression have the potential to suppress the activation of CD4+ T cells, monocytes and Mast cells [18,19]. This evidence concerns the gene SERPINA3 and central nervous system cancer.